Move Study in Healthy Aging People
Effects of a Test Formula Milk Powder Combined With a Physical Activity Program on Mobility in Healthy Aging Subjects With Joint Discomfort
1 other identifier
interventional
55
1 country
1
Brief Summary
Bone and muscle losses occur during ageing leading to increased risk of osteoporosis (there are more than 200 million people affected by osteoporosis worldwide), sarcopenia, loss of functionality and mobility. From around 45-50 years onwards, there is a progressive loss of muscle mass and strength (sarcopenia). This is partially due to an impairment of muscle protein synthesis in response to dietary proteins. Insufficient dietary protein may contribute to age-related loss of lean body mass (LBM) and strength which ultimately affects body movement. Key ingredients in selected investigational product are:Milk proteins, Calcium, Vitamin D, Vitamin C, Glucosamine Sulfate, Zinc. They have effects to improve physical mobility and functionality. The investigators expect improved effects of a nutritional intervention combined with a physical activity program on mobility in healthy aging subjects with joint discomfort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 21, 2014
CompletedFirst Posted
Study publicly available on registry
October 28, 2014
CompletedStudy Start
First participant enrolled
April 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2016
CompletedNovember 28, 2016
November 1, 2016
1.3 years
October 21, 2014
November 24, 2016
Conditions
Outcome Measures
Primary Outcomes (1)
Change from baseline in muscle extension isokinetic strength and 4 min speed step
Change from baseline and muscle(quadriceps)extension isokinetic strength (peak torque) and 4 min speed step will be measured as the change of musculoskeletal functionality and mobitliy.
Baseline and visit 7
Study Arms (1)
Arm1, Nutrition intervention, test formula and activity
EXPERIMENTALInterventions
Tai Chi; dynamic strength training (knee extension, knee flexion, hip extension, side leg raise, plantar flexion); flexibility warm up and cool down (shoulder and upper arm stretch, hamstrings stretch, calf stretch, ankle stretch); aerobic fitness training(walking on even flat ground); balance training(standing on one foot; heel-to-toe walk; toe stand)
Eligibility Criteria
You may qualify if:
- Target 45-65 y old
- Suffering from (knee) pain. VAS on pain assessment \<= 4 on a range 0 to 10
- \<BMI\<28
- Time since menopause above 2y
- iPAQ (International Physical Activity Questionnaire) score \<600
You may not qualify if:
- OA diagnosed
- Medicine treatment
- Chronic pain killers treatment for more than 7 consecutive days with a washout period of 2 weeks between 2 periods of treatment
- Under corticoid, hormone (adrenal, thyroid) treatment
- Traditional herbal medicine: in particular with claims on strengthening tendons and bones. This point will be included in FFQ (see annex) and evaluate.
- Subjects with chronic tablets supplementation ( calcium or drinking milk over 5 day wk-1 will be excluded, vitamin D, GS, or any with effect on bone and joints ) (set up a FFQ to specially investigate intakes of calcium tablets, milk and animal foods)
- Pregnancy
- Subject with knee/joint surgery/replacement and CLA (Cross Ligament) injury
- History of relevant digestive disease, organic disease of heart, liver or kidney, severe function disorder of liver or kidney, metabolic/endocrine , neurological disease (e.g., Parkinson disease, stroke) with residual impairment, vertigo
- Anaemia
- Unable to carry out functional tests and questionnaires correctly (KOOS, physical activity)
- Lower or upper extremity surgery or fracture in the last 3 months
- Currently participating or having participated in another clinical trial in the three previous months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University Third Hospital
Beijing, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 21, 2014
First Posted
October 28, 2014
Study Start
April 1, 2015
Primary Completion
August 1, 2016
Study Completion
August 1, 2016
Last Updated
November 28, 2016
Record last verified: 2016-11